The short answer: More than many of its peers, at least in terms of yield.Medtronic (MDT -1.12%), a beast of a medical-device company, has caught the eye of more than a few income investors. It has enacted dividend raises at least once annually for a hard-to-beat 47 years straight and approaches high-yield dividend territory with a payout hovering just below 4%. As that distribution is a major part of the stock's popularity, it's worth looking at a key number behind it -- quite simply, how much will it amou ...

shapecharge/E+ via Getty Images Introduction Medtronic (NYSE:MDT) has been an underperformer over the last few years. However, with the recent pullback while earnings have continued to climb higher, I think shares of Medtronic are cheap at the current price. My bullish investment thesis is driven by my optimistic outlook on the EPS growth long-term, which is sustained by growth in medtech markets and a huge pipeline of products. I rate shares as a 'buy' with a view towards shareholder friendly capital alloc ...

Core Insights - The integration of artificial intelligence (AI) in healthcare is poised to enhance patient outcomes through improved diagnostics and data processing capabilities, potentially creating a new segment in the stock market that merges technology and biotechnology [1] Group 1: AI Healthcare Stocks Overview - AI healthcare stocks are still largely speculative but should be evaluated based on the number of patients and conditions they can address using AI technology [1] - The vast amounts of health data collected for training AI systems are highly valuable, contributing to the worth of AI healthcare stocks [1] Group 2: Recursion Pharmaceuticals (RXRX) - Recursion Pharmaceuticals aims to transform clinical-stage biotechnology through algorithmic applications, focusing on reducing the time and cost of drug production [2] - The company is in early stages and lacks a proven track record of marketable drugs, but its proprietary software platform automates lab experiments and data collection, compiling a significant biological and chemical dataset [2][3] - RXRX's application of supercomputing technology and custom-trained AI could revolutionize drug research and production, making it a noteworthy AI healthcare stock despite its recent challenges [3] Group 3: Novartis (NVS) - Novartis has integrated AI into its processes, utilizing it for Generative Chemistry, AE Brain, and AI Nurse applications to enhance drug development and patient engagement [4][5] - The company employs top chemists and has successfully brought over 90 products to market, indicating a strong position in the pharmaceutical industry [5] - Novartis's broad approach to AI in healthcare makes it a compelling investment opportunity [5] Group 4: Medtronic (MDT) - Medtronic is recognized for its innovative AI healthcare technologies, particularly the GI Genius, an AI-based endoscopy module that improves the detection of colorectal polyps [6] - The company's focus on technology development for healthcare applications positions it favorably as the industry increasingly adopts AI solutions [6][7] - Medtronic's advancements in AI are seen as a positive indicator for potential investment as the healthcare sector evolves [7]

Medtronic (MDT) closed at $77.12 in the last trading session, reflecting more than a 2% decline from the prior day. Broadly speaking, 2024 has not been smooth for investors in the Medical Products industry. Rising geopolitical pressure, primarily disruptions around the Red Sea, has increased freight costs and shipping lead times, spelling trouble for MDT and several of its direct competitors, like Abbott (ABT) and Boston Scientific (BSX) , thus putting pressure on their margins.Thankfully, there has been an ...

Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Medtronic Plc - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering.The report provides comprehensive information and insights into Medtronic's technology activities, focusing on its digital transformation strategies and innovation programs. It offers an overview of Medtronic's technology initiatives, covering partnerships, product launches, and acquisitions. Each technology initiative is detailed with insight ...

Medtronic plc (MDT) recently shared a comprehensive set of new data emphasizing the benefits of the MiniMed 780G insulin pump system. The latest findings demonstrate how the system addresses hyperglycemia and nighttime burden, adding to the pool of evidence proving the system's ability to tackle the difficulties of diabetes, such as managing highs and meal-time management or carb counting while mirroring outcomes across a diverse population.The company presented the series of data at the American Diabetes A ...

With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep DUBLIN and ORLANDO, Fla., June 21, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that showcases the benefits of th ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934. For the fiscal year ended April 26, 2024. ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File No. 1-36820 ® Medtronic plc (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State or other jurisdiction of in ...

The robots aren’t coming. They’re already here. From assembly lines and warehouse operations to surgical centers and home assistants, the robot revolution is in full-swing. But while regular people today are using robots to vacuum their homes and turn off their lights, a growing number of companies are pushing into the red hot field of robotics on a much larger scale. That makes now a great time to look at robotics stocks to buy.There appears to be no slowing down the momentum behind robots, especially with ...

TROY, Mich., June 14, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) as its "Stock to Study" and Medtronic PLC (NYSE: MDT) as its "Undervalued Stock" in the September 2024 issue for investors' informational and educational use."With GameStop back in the headlines, the siren song of easy money has returned, luring the unschooled down treacherous paths. The National Association of Investors c ...